Autochthonous mouse models of thyroid cancer dedifferentiation and immune microenvironment remodeling

Introduction Follicular cell-derived thyroid cancers can lose lineage function, develop high-grade morphology and remodel their immune microenvironment along different trajectories. We examined how autochthonous genetically engineered mouse models reproduce these processes and support mechanistic immune studies. Methods PubMed was searched on 1 October 2026, supplemented by citation checking. Eligible evidence comprised genetically engineered follicular-cell thyroid tumors or initiating lesions, with immunocompetent thyroid-tumor grafts considered separately. One researcher screened records and a second checked the decisions. Selected comparisons were synthesized narratively by model, platform and endpoint. A SYRCLE-informed, design-adapted framework was used for comparison-specific appraisal. Results Among 1,683 unique records, 210 reports were retained: 192 autochthonous-model reports and 18 complementary graft reports. Thirty-one reports were unavailable for source assessment, two remained unclassified and one retained report had abstract-only access. The appraisal included 205 specified comparisons; four technical reports were inapplicable and the abstract-only report was not assessable. Driver and cooperator configurations captured different aspects of initiation, progression and treatment response. Immune evidence supported selected CSF1/CSF1R-associated myeloid mechanisms and platform-specific MHC-II/CD4 responses to MAPK inhibition. Checkpoint-combination outcomes differed across models, including a negative autochthonous study. Spatial findings identified macrophage distributions and early lymphoid niches without establishing mature tertiary lymphoid structures across models. Discussion Model selection should follow the research question, disease stage and measured endpoint. Lineage recovery, immune activation, tumor control and durable benefit require separate evaluation. Limitations include a single-database search, incomplete full-text access, selected comparison-level extraction, limited source reporting and undocumented completion of author verification of the current extraction and appraisal records. The review was not registered. Funding was provided by the National Natural Science Foundation of China and the Liaoning Provincial Science and Technology Plan.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-19
DOI
https://doi.org/10.3389/fimmu.2026.1979134
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Autochthonous mouse models of thyroid cancer dedifferentiation and immune microenvironment remodeling

Hetong Wang, Yujian Guan, Zeyu Li, Dalin Zhang et al.
Frontiers in Immunology
Thyroid Cancer Diagnosis and Treatment
article

Autochthonous mouse models of thyroid cancer dedifferentiation and immune microenvironment remodeling

Hetong Wang, Yujian Guan, Zeyu Li, Dalin Zhang, Guoan Zhao, Jiapeng Huang, Zhihong Wang, Qi Liu, Xiupeng Zhang, Rui Xi, Yang Shi, Hao Zhang
article en

Abstract

Introduction Follicular cell-derived thyroid cancers can lose lineage function, develop high-grade morphology and remodel their immune microenvironment along different trajectories. We examined how autochthonous genetically engineered mouse models reproduce these processes and support mechanistic immune studies. Methods PubMed was searched on 1 October 2026, supplemented by citation checking. Eligible evidence comprised genetically engineered follicular-cell thyroid tumors or initiating lesions, with immunocompetent thyroid-tumor grafts considered separately. One researcher screened records and a second checked the decisions. Selected comparisons were synthesized narratively by model, platform and endpoint. A SYRCLE-informed, design-adapted framework was used for comparison-specific appraisal. Results Among 1,683 unique records, 210 reports were retained: 192 autochthonous-model reports and 18 complementary graft reports. Thirty-one reports were unavailable for source assessment, two remained unclassified and one retained report had abstract-only access. The appraisal included 205 specified comparisons; four technical reports were inapplicable and the abstract-only report was not assessable. Driver and cooperator configurations captured different aspects of initiation, progression and treatment response. Immune evidence supported selected CSF1/CSF1R-associated myeloid mechanisms and platform-specific MHC-II/CD4 responses to MAPK inhibition. Checkpoint-combination outcomes differed across models, including a negative autochthonous study. Spatial findings identified macrophage distributions and early lymphoid niches without establishing mature tertiary lymphoid structures across models. Discussion Model selection should follow the research question, disease stage and measured endpoint. Lineage recovery, immune activation, tumor control and durable benefit require separate evaluation. Limitations include a single-database search, incomplete full-text access, selected comparison-level extraction, limited source reporting and undocumented completion of author verification of the current extraction and appraisal records. The review was not registered. Funding was provided by the National Natural Science Foundation of China and the Liaoning Provincial Science and Technology Plan.

Frontiers in ImmunologyVol. 17
First Hospital of China Medical University (CN), China Medical University (CN)
Thyroid Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon